 | • レポートコード：MRC23Q36389 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、65ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の変形性関節症幹細胞治療市場について調査・分析し、世界の変形性関節症幹細胞治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（同種、自家）、用途別セグメント分析（原発性変形性関節症、二次性変形性関節症）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Medipost、Nature Cell、Theracell Advanced Biotechnology、Takeda (TiGenix)などが含まれています。世界の変形性関節症幹細胞治療市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、変形性関節症幹細胞治療市場規模を推定する際に考慮しました。本レポートは、変形性関節症幹細胞治療の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、変形性関節症幹細胞治療に関するビジネス上の意思決定に役立てることを目的としています。 ・変形性関節症幹細胞治療市場の概要 - 変形性関節症幹細胞治療のタイプ別セグメント - 世界の変形性関節症幹細胞治療市場規模：タイプ別分析（同種、自家） - 変形性関節症幹細胞治療の用途別セグメント - 世界の変形性関節症幹細胞治療市場規模：用途別分析（原発性変形性関節症、二次性変形性関節症） - 世界の変形性関節症幹細胞治療市場規模予測（2018年-2029年） ・変形性関節症幹細胞治療市場の成長トレンド - 変形性関節症幹細胞治療の地域別市場規模（2018年-2029年） - 変形性関節症幹細胞治療市場ダイナミクス - 変形性関節症幹細胞治療の業界動向 - 変形性関節症幹細胞治療市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：同種、自家 - 世界の変形性関節症幹細胞治療のタイプ別市場規模（2018年-2023年） - 世界の変形性関節症幹細胞治療のタイプ別市場規模（2024年-2029年） ・用途別セグメント：原発性変形性関節症、二次性変形性関節症 - 世界の変形性関節症幹細胞治療の用途別市場規模（2018年-2023年） - 世界の変形性関節症幹細胞治療の用途別市場規模（2024年-2029年） ・変形性関節症幹細胞治療の地域別市場規模 - 北米の変形性関節症幹細胞治療市場規模（2018年-2029年） - アメリカの変形性関節症幹細胞治療市場規模（2018年-2029年） - ヨーロッパの変形性関節症幹細胞治療市場規模（2018年-2029年） - アジア太平洋の変形性関節症幹細胞治療市場規模（2018年-2029年） - 中国の変形性関節症幹細胞治療市場規模（2018年-2029年） - 日本の変形性関節症幹細胞治療市場規模（2018年-2029年） - 韓国の変形性関節症幹細胞治療市場規模（2018年-2029年） - インドの変形性関節症幹細胞治療市場規模（2018年-2029年） - オーストラリアの変形性関節症幹細胞治療市場規模（2018年-2029年） - 中南米の変形性関節症幹細胞治療市場規模（2018年-2029年） - 中東・アフリカの変形性関節症幹細胞治療市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Medipost、Nature Cell、Theracell Advanced Biotechnology、Takeda (TiGenix) ・アナリストの観点/結論 ・調査方法とデータソース |
OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility.
Stem cells are the body’s raw materials — cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells either become new stem cells (self-renewal) or become specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells or bone cells. No other cell in the body has the natural ability to generate new cell types.
Most stem cells used for the experimental treatment of OA are adult MSCs. Researchers can easily collect them from fat or bone marrow. MSCs are able to turn into cartilage, bone, muscle, tendon, ligaments, or fat, depending on the type of tissue that surrounds them. This is why researchers are studying MSCs in stem cell treatments for OA.
Highlights
The global Stem Cell Therapy for Osteoarthritis market was valued at US$ 28 million in 2022 and is anticipated to reach US$ 107.3 million by 2029, witnessing a CAGR of 25.1% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the global market, the core manufacturers of Stem cell therapy for osteoarthritis include Medipost etc, and the top 1 manufacturer accounts for about 80% of the market share. The market include Asia Pacific and Europe, with a share of 90% and 10%. allogeneic accounted for 90% and autologous accounted for 10%. the product is mainly used in primary osteoarthritis and secondary osteoarthritis fields, with a share of 92% and 8%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy for Osteoarthritis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy for Osteoarthritis.
The Stem Cell Therapy for Osteoarthritis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Stem Cell Therapy for Osteoarthritis market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stem Cell Therapy for Osteoarthritis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Medipost
Nature Cell
Theracell Advanced Biotechnology
Takeda (TiGenix)
Segment by Type
Allogeneic
Autologous
Segment by Application
Primary Osteoarthritis
Secondary Osteoarthritis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stem Cell Therapy for Osteoarthritis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Allogeneic
1.2.3 Autologous
1.3 Market by Application
1.3.1 Global Stem Cell Therapy for Osteoarthritis Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Primary Osteoarthritis
1.3.3 Secondary Osteoarthritis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy for Osteoarthritis Market Perspective (2018-2029)
2.2 Stem Cell Therapy for Osteoarthritis Growth Trends by Region
2.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Stem Cell Therapy for Osteoarthritis Historic Market Size by Region (2018-2023)
2.2.3 Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Region (2024-2029)
2.3 Stem Cell Therapy for Osteoarthritis Market Dynamics
2.3.1 Stem Cell Therapy for Osteoarthritis Industry Trends
2.3.2 Stem Cell Therapy for Osteoarthritis Market Drivers
2.3.3 Stem Cell Therapy for Osteoarthritis Market Challenges
2.3.4 Stem Cell Therapy for Osteoarthritis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue
3.1.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue (2018-2023)
3.1.2 Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Players (2018-2023)
3.2 Global Stem Cell Therapy for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Stem Cell Therapy for Osteoarthritis Revenue
3.4 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio
3.4.1 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Osteoarthritis Revenue in 2022
3.5 Stem Cell Therapy for Osteoarthritis Key Players Head office and Area Served
3.6 Key Players Stem Cell Therapy for Osteoarthritis Product Solution and Service
3.7 Date of Enter into Stem Cell Therapy for Osteoarthritis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Therapy for Osteoarthritis Breakdown Data by Type
4.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Type (2018-2023)
4.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2024-2029)
5 Stem Cell Therapy for Osteoarthritis Breakdown Data by Application
5.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Application (2018-2023)
5.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Stem Cell Therapy for Osteoarthritis Market Size (2018-2029)
6.2 North America Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2018-2023)
6.4 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cell Therapy for Osteoarthritis Market Size (2018-2029)
7.2 Europe Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2018-2023)
7.4 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size (2018-2029)
8.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2018-2023)
8.4 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size (2018-2029)
9.2 Latin America Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2018-2023)
9.4 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size (2018-2029)
10.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2018-2023)
10.4 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medipost
11.1.1 Medipost Company Detail
11.1.2 Medipost Business Overview
11.1.3 Medipost Stem Cell Therapy for Osteoarthritis Introduction
11.1.4 Medipost Revenue in Stem Cell Therapy for Osteoarthritis Business (2018-2023)
11.1.5 Medipost Recent Development
11.2 Nature Cell
11.2.1 Nature Cell Company Detail
11.2.2 Nature Cell Business Overview
11.2.3 Nature Cell Stem Cell Therapy for Osteoarthritis Introduction
11.2.4 Nature Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2018-2023)
11.2.5 Nature Cell Recent Development
11.3 Theracell Advanced Biotechnology
11.3.1 Theracell Advanced Biotechnology Company Detail
11.3.2 Theracell Advanced Biotechnology Business Overview
11.3.3 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Introduction
11.3.4 Theracell Advanced Biotechnology Revenue in Stem Cell Therapy for Osteoarthritis Business (2018-2023)
11.3.5 Theracell Advanced Biotechnology Recent Development
11.4 Takeda (TiGenix)
11.4.1 Takeda (TiGenix) Company Detail
11.4.2 Takeda (TiGenix) Business Overview
11.4.3 Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Introduction
11.4.4 Takeda (TiGenix) Revenue in Stem Cell Therapy for Osteoarthritis Business (2018-2023)
11.4.5 Takeda (TiGenix) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details